Skip to main content

Table 1 Univariate and multivariate analysis for disease-free survival in total 290 cases

From: LINC00309 is associated with short disease-free survival in breast cancer

 

Univariate analysis

Multivariate analysis

Hazard ratio (95% CI)

pa value

Hazard ratio (95% CI)

pa value

Age

 > 40 vs. ≤ 40

1.618 (0.828–3.159)

0.159

1.386 (0.695–2.762)

0.354

Tumor size

 ≤ 2 vs. > 2

1.444 (0.865–2.410)

0.159

1.133 (0.651–1.9718)

0.434

Lymph node status

 Negative vs. positive

5.855 (1.045–1.518)

0.016

1.544 (1.102–1.529)

0.002

Vessel invasion

 Negative vs. positive

2.311 (1.304–4.097)

0.004

1.779 (0.816–2.924)

0.182

ER status

 Negative vs. positive

0.703 (0.396–1.250)

0.230

0.150 (0.023–0.974)

0.057

PR status

 Negative vs. positive

0.807 (0.453–1.438)

0.467

5.466 (0.831–35.955)

0.077

Ki-67

 Negative vs. positive

1.911 (1.075–3.395)

0.027

1.053 (1.053–3.733)

0.034

HER-2/neu status

 Negative vs. positive

0.712 (0.403–1.260)

0.244

0.324 (0.324–1.143)

0.123

LINC00309

 Low vs. high

1.990 (1.069–3.703)

0.030

2.127 (1.074–4.212)

0.030

  1. CI confidence interval, HER-2 human epidermal growth factor receptor 2, PR progesterone receptor
  2. ap is based on the Cox regression test